Selective Estrogen Receptor Modulators (SERMs) really are a cornerstone of pharmaceutical PCT interventions. They perform as competitive inhibitors at estrogen receptors while in the hypothalamus while exhibiting tissue-selective agonist or antagonist Attributes throughout the human body. SERMs are vital in regulating post cycle estrogen output and